This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
PKC Antibody
catalog :
2059
reactivity :
human
application :
western blot
citations: 7
Published Application/Species/DilutionReference
  • western blot; human; 1:1000; fig 6
Leung C, Yeung T, Yip K, Pradeep S, Balasubramanian L, Liu J, et al. Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential. Nat Commun. 2014;5:5092 pubmed publisher
Ruzsnavszky O, Dienes B, Oláh T, Vincze J, Gáll T, Balogh E, et al. Differential effects of phosphatase inhibitors on the calcium homeostasis and migration of HaCaT keratinocytes. PLoS ONE. 2013;8:e61507 pubmed publisher
Hirschi A, Cecchini M, Steinhardt R, Schamber M, Dick F, Rubin S. An overlapping kinase and phosphatase docking site regulates activity of the retinoblastoma protein. Nat Struct Mol Biol. 2010;17:1051-7 pubmed publisher
Giambra V, Jenkins C, Wang H, Lam S, Shevchuk O, Nemirovsky O, et al. NOTCH1 promotes T cell leukemia-initiating activity by RUNX-mediated regulation of PKC-θ and reactive oxygen species. Nat Med. 2012;18:1693-8 pubmed publisher
Kaneko-Kawano T, Takasu F, Naoki H, Sakumura Y, Ishii S, Ueba T, et al. Dynamic regulation of myosin light chain phosphorylation by Rho-kinase. PLoS ONE. 2012;7:e39269 pubmed publisher
Puig-Butille J, Malvehy J, Potrony M, Trullas C, Garcia-Garcia F, Dopazo J, et al. Role of CPI-17 in restoring skin homoeostasis in cutaneous field of cancerization: effects of topical application of a film-forming medical device containing photolyase and UV filters. Exp Dermatol. 2013;22:494-6 pubmed publisher
Gromova P, Ralea S, Lefort A, Libert F, Rubin B, Erneux C, et al. Kit K641E oncogene up-regulates Sprouty homolog 4 and trophoblast glycoprotein in interstitial cells of Cajal in a murine model of gastrointestinal stromal tumours. J Cell Mol Med. 2009;13:1536-48 pubmed publisher
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.